Pharmacovigilance in Israel – tools, processes, and actions

BACKGROUND: Due to the limited safety data available at the time that a new medication is first marketed, it is essential to continue the collection and monitoring of safety data about adverse drug reactions (ADRs) during the medication’s life cycle. This activity, known as pharmacovigilance (PV), i...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartzberg, Eyal, Berkovitch, Matitiahu, Dil Nahlieli, Dorit, Nathan, Joseph, Gorelik, Einat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537943/
https://www.ncbi.nlm.nih.gov/pubmed/28760141
http://dx.doi.org/10.1186/s13584-017-0154-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537943/
https://www.ncbi.nlm.nih.gov/pubmed/28760141
http://dx.doi.org/10.1186/s13584-017-0154-3

Ejemplares similares